Emerald Compounding Pharmacy: Licensing, Sterile Credentials and Verification

Pharmacy identity and overview

A pharmacy licence is issued to a location, so the address is the anchor that makes every later check meaningful. The details below are the ones printed on the Florida record, with no embellishment.

Legal name

Emerald Compounding Pharmacy LLC

Physical address

5325 Primrose Lake Circle, Suite A, Tampa Palms, Florida 33647

Facility type

Florida-licensed community pharmacy with a special sterile compounding qualification

Records read

November 1, 2026

An independent compounding pharmacy in Tampa Palms, Florida, recorded as one of the named pharmacy partners on Surfbound Health’s published pharmacy page. The facility is not described here as a 503B outsourcing facility, because nothing in the records read supports that description: the licences verified are state pharmacy licences. The pharmacy directory explains how the two federal categories differ and why neither is a quality grade.

Verified Florida qualifications

Florida is the state the facility physically operates in, so its licence is the primary record. Read on November 1, 2026, it shows:

• Licence number PH35337, printed with a status of “Clear”.
• Special sterile compounding qualification recorded against the licence. This is the field that separates a facility the state recognises for sterile preparation from one licensed only to dispense.
• Expiry February 28, 2027, read from the record rather than assumed to renew.
• No discipline recorded on that Florida record as of the check date.

The record is public and the check is repeatable in about a minute: Florida Department of Health, licence verification for PH35337 (opens in a new tab).

What this licence does not mean is worth stating in the same breath. A sterile compounding qualification is a permitted scope of practice, not a certificate about any individual preparation. It does not report sterility testing, endotoxin results, potency assays or environmental monitoring for a batch, and it does not make the pharmacy the safest of its kind. USP General Chapter <797> sets the standards that sit behind the qualification, published by USP here (opens in a new tab); compliance with it is assessed by the board, not printed as a per-batch result.

Verified Oklahoma nonresident authorization

A second, out-of-state authorisation is a separate record with its own status and expiry. For Emerald Compounding Pharmacy LLC, the Oklahoma record read on November 1, 2026 shows:

• Nonresident licence 99-10164, shown in good standing.
• Sterile compounding: authorised, recorded on that record.
• Expiry April 30, 2027.
• No disciplinary action shown in that Oklahoma record as of the check date.

The source is Oklahoma State Board of Pharmacy, licence detail for 99-10164 (opens in a new tab).

Two licences in two states is normal for a pharmacy that dispenses beyond its home state, and it means the facility has been through two independent reviews. It does not mean a full set of states has been checked. Nonresident licences exist for some states and not others, so the list this page can verify is always partial evidence, and it is presented that way rather than as a national clearance.

Public licensing and disciplinary-record results

Both boards publish an enforcement or disciplinary search beside the licence lookup, and both were read for these two licence numbers on November 1, 2026.

No published disciplinary action appears on the Florida record for PH35337 or the Oklahoma record for 99-10164 as of November 1, 2026. That is the whole of the finding, and the precision matters: it is a dated statement about two jurisdictions and two licence numbers.

It does not mean no complaint was ever filed anywhere, that no closed matter never existed, or that any other state’s file is clean. A clean public record means nothing is published against these licences, which is a narrower claim than nothing happened. A reader who needs more should search the boards directly, using the licence numbers above rather than the pharmacy’s trading name, because a trading name search can miss a record filed under the licensed entity.

Additional credentials published by Emerald

A pharmacy’s own site is a legitimate place to learn what it claims, and it is a different class of evidence from a board’s licence record. This page keeps the two visibly apart rather than printing both in the same voice.

The pharmacy publishes a certificates page at emeraldsrx.com/certificates (opens in a new tab), read on November 2, 2026. On that page it reproduces its community-pharmacy licence, sterile qualification, registrations and LegitScript certification. The licence details reproduced there agree with the two state records on this page. The LegitScript entry was not lifted from LegitScript’s own registry during this check, so it is printed as pharmacy-reported rather than independently verified.

The same rule applies to any certification graphic, seal or badge on a pharmacy or program page. A seal is a picture until the certifying body’s own register shows the entry, which is why this page carries no certificate image and makes no accreditation claim at all. No NABP, PCAB, ACHC or FDA approval is asserted for this facility, and the absence of that assertion is deliberate rather than an oversight.

For the regulatory context behind that distinction, the FDA’s own material on the risks of compounded drugs (opens in a new tab) and on compounding and the FDA (opens in a new tab) is worth reading once. Neither page is an approval, and neither is a warning against compounding as such. A compounded preparation is not an FDA-approved finished drug product, and that is true of every compounded GLP-1 preparation regardless of which licensed pharmacy prepared it.

Why a sterile-compounding credential is the one that matters here

A GLP-1 medication is injected through the skin, which means a preparation that would be harmless in a swallowed tablet becomes a direct route into the body. That difference is what a sterile qualification is for, and it is why the field is worth looking up rather than assuming.

A pharmacy licence alone permits dispensing. A licence carrying a special sterile compounding qualification is the state recording that the facility is recognised for preparing sterile medicines — the category that covers injectables, and the category a patient searching for a compounded GLP-1 actually needs. Emerald holds that qualification in Florida, where the facility physically sits, and a matching sterile authorisation on its Oklahoma nonresident record. That is two independent boards recording the same capability.

Behind the qualification sits a standard: USP General Chapter <797> sets the requirements for sterile compounding — the cleanroom classification, the air sampling, the gowning, the beyond-use dating and the testing regime. The chapter is published by USP here (opens in a new tab). Compliance with it is what the board assesses when it grants and renews a sterile qualification, and it is the reason that field, rather than the licence number, is the one to read.

The practical value for a buyer is narrower than it sounds, and still real. Most programs in this market will name a pharmacy or a network if asked. Very few make it easy to check whether that pharmacy is authorised for sterile work at all. Emerald’s answer to that question is on a public register in two states, with a status word and an expiry date, which is the strongest form this particular fact takes.

What a patient can verify before a prescription is filled

The checks below can be run against Emerald Compounding Pharmacy LLC using the two records linked on this page, and they can be run against any other compounding pharmacy a program names. They take a few minutes each and they produce facts rather than impressions.

1. Step 1

   Match the name on the paperwork to the name on the licence

   A trading name and a licensed legal entity are often different strings. Read the licence for the licensee name and the address, then compare both with what appears on your order confirmation.

2. Step 2

   Read the licence for a sterile qualification, not just a pharmacy licence

   The entry ticket is a pharmacy licence. The field that matters for an injectable is the one recording a sterile or compounding qualification, because that is what separates a facility the state recognises for sterile preparation from one that only dispenses.

3. Step 3

   Check every state the pharmacy ships into

   A pharmacy dispensing into your state from another one may need a nonresident licence there, with its own status and expiry date. Two licences in two states is normal. What cannot be concluded is that a full set of states has been checked, because no consumer-facing register assembles that for you.

4. Step 4

   Search the disciplinary file by licence number, and date your finding

   Search the number rather than the trading name. "No discipline on record as of a date" is precise and useful. "No complaints ever" is not something a register can tell you, and a page claiming it is guessing.

5. Step 5

   Ask for the quality documentation the register cannot give you

   Before ordering, ask which pharmacy will dispense your prescription and whether it can supply the sterility and endotoxin testing summary for the batch, plus its beyond-use dating policy. A company that will not answer the first part is telling you something about its disclosure.

After those five steps you have established that a real business at a real address holds a current licence, in at least one state and possibly more, that specifically authorises sterile compounding, with nothing published against it on November 1, 2026. That is meaningful, and it is also compatible with a batch having failed an endotoxin test the previous week, because no register reports that. The full method for verifying a sterile compounding pharmacy walks through each layer in more detail, including the tests this page is not able to report.

Emerald’s role among Surfbound Health’s named pharmacy partners

Emerald Compounding Pharmacy LLC is one of the independent licensed pharmacies that Surfbound Health names publicly on its own pharmacy page. That sentence is worth reading precisely, because most of the confusion in this part of the market comes from collapsing it into something shorter.

• Surfbound is a telehealth program, not the pharmacy. It handles enrollment, billing and the clinical relationship. The medicine is compounded and dispensed by a licensed pharmacy, a separate business with its own licence and its own regulator.
• A licensed provider decides whether to prescribe. Whether a prescription is written at all is a clinical decision made by a licensed clinician, not a purchase that clears because a payment went through.
• The fulfillment pharmacy varies by prescription. Naming Emerald as a partner is a statement about the network, not about your order. Which facility prepares a given prescription depends on the prescription and the fulfillment process on the day it is filled.
• No guarantee is made that Emerald dispenses every order. Neither Surfbound’s page nor this record promises that. The document that names your dispensing pharmacy is the paperwork that arrives with the shipment, and that is the one to check against the directory.

Publisher note: GLP1 Buyer Guide and Surfbound Health are operated by Open Water Rx LLC. The full statement is on disclosures.

The program’s recorded costs and terms are on its provider profile, and the dispensing category Surfbound records for its orders is kept on its directory entry. Neither page is a substitute for the licence check above: naming a partner earns the ability to be checked, not a pass.

Source references

Regulator records, read November 1, 2026

• Florida Department of Health — Emerald Compounding Pharmacy LLC, licence PH35337: licence verification record (opens in a new tab). Status “Clear”, special sterile compounding qualification, expires February 28, 2027.
• Oklahoma State Board of Pharmacy — Emerald Compounding Pharmacy LLC, licence 99-10164: licence detail (opens in a new tab). Good standing, sterile compounding authorised, expires April 30, 2027.

Pharmacy-reported material, read November 2, 2026

• Emerald Compounding Pharmacy LLC — own certificates page: emeraldsrx.com/certificates (opens in a new tab). Reproduces the community-pharmacy licence, sterile qualification, registrations and a claimed LegitScript certification; printed here as pharmacy-reported.

Program disclosure and standards

• Surfbound Health — published pharmacy partners: surfbound.co/pharmacies (opens in a new tab), read November 1, 2026. Emerald is one of several named independent partners.
• United States Pharmacopeia — General Chapter <797>, compounded sterile preparations: USP publication record (opens in a new tab).
• U.S. Food and Drug Administration — compounding and FDA, questions and answers (opens in a new tab) and the risks of compounded drugs (opens in a new tab).

The full claim record

Every factual statement on this page is listed below against the evidence behind it. A claim that no public record supports stays in the table labelled Not established, and a claim the pharmacy makes about itself is labelled Pharmacy-reported rather than promoted to a finding.

How this record was made

The same dated-source rule the rest of GLP1 Buyer Guide uses applies here, with prices replaced by licence records: a fact is printed with the date it was checked, and a field the public record is silent on stays blank or is labelled Not established rather than filled with a guess. The method is published on how we compare, and the ownership relationship and advertising policy are stated once in full on disclosures.

• The pharmacy directory — the dispensing categories recorded behind each program group.
• Surfbound Health’s dispensing category — the category recorded for its orders, not a named supplier per prescription.
• How to verify a sterile GLP-1 compounding pharmacy — the full method, including the tests this page cannot report.
• Surfbound Health, program by program — costs, terms and the recorded pharmacy disclosure.
• Comparing the programs that use named pharmacy partners — the ranked index, with each program’s recorded price and terms kept apart from its place.
• How we compare — why a blank value and a labelled gap are treated as findings.